Revenue: The sum of all revenue fields included for a company's operating activities.
Swedish Orphan Biovitrum (BIOVF) had Revenue of $2.46B for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$2.46B |
$367.52M |
|
$547.26M |
|
$1.91B |
|
$1.93B |
|
$532.13M |
|
$-115.32M |
|
$416.90M |
|
$416.90M |
|
$366.95M |
|
$366.95M |
|
$366.95M |
|
$366.95M |
|
$532.13M |
|
$880.16M |
|
341.73M |
|
345.56M |
|
$1.08 |
|
$1.06 |
|
| Balance Sheet Financials | |
$1.25B |
|
$149.85M |
|
$5.89B |
|
$7.14B |
|
$1.19B |
|
$1.17B |
|
$2.13B |
|
$3.33B |
|
$3.81B |
|
$-1.77B |
|
$3.81B |
|
343.44M |
|
| Cash Flow Statement Financials | |
$698.90M |
|
$-292.41M |
|
$-378.49M |
|
$85.52M |
|
$107.84M |
|
$22.33M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|